Tū Ātea and Mavenir Partner to Pioneer Future of Networks Using Māori Spectrum Assets 14-11-2024, 21:38

Bedford Metals Provides Corporate Update on Uranium Exploration Progress 6-09-2024, 12:00

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as 2-11-2024, 02:00